NCT01231347 2024-07-16
GAMMA
NantCell, Inc.
Phase 3 Completed
Clinical Trials
10 trialsNCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT05395013 2022-06-07
NEOSTENT
Azienda Unità Sanitaria Locale della Romagna
Completed
NCT01905384 2022-03-31
Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction
Vanderbilt University Medical Center
Phase NA Completed
NCT02787512 2019-02-12
Preoperative Biliary Drainage With Metal Versus Plastic Stents in Periampullary Cancer
Seoul National University Hospital
Phase NA Completed
NCT00980889 2014-04-08
RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction
Stockholm South General Hospital
Phase 4 Completed
NCT02098239 2014-03-27
Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.
Cancer Advances Inc.
Phase 2 Completed
NCT01356030 2013-07-09
Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer
California Pacific Medical Center Research Institute
Phase NA Completed
NCT01459965 2011-10-26
Stenting Malignant Jaundice for Quality of Life
Indiana University
Phase NA Completed
NCT00196105 2011-10-03
Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)
Cook Group Incorporated
Phase NA Completed